Peregrine Ventures’ Post

Thrilled to announce another milestone for Momentis Surgical™ , one of our pioneering #medical device portfolio companies, as they secure additional #FDA 510(k) clearance for their Anovo™ robotic platform—the world’s first single-port robotics system—now also approved for laparoscopic ventral hernia repairs. The platform enables surgeons to perform complex, minimally invasive procedures with the goal of enhancing patient outcomes and reducing healthcare costs. Frederic H. Moll, M.D., a Momentis board member and founder of Intuitive Surgical and Auris Health, shared, “This technology is clearly differentiating and will have an immediate impact on the way general surgery is performed.” What makes Anovo™ unique is its compact, mobile design, allowing it to be used in both hospitals and outpatient settings, including ambulatory surgical centers—making it more accessible than traditional robotic systems. Momentis began its journey in Peregrine’s Incentive, Peregrine Ventures Incubator in 2013, under the leadership of CEO Dvir Cohen. Peregrine’s Eyal Lifschitz, alongside the Peregrine team, has had the privilege of guiding and supporting Momentis through this incredible journey. We look forward to seeing the positive impact it will have on patients' lives. #Health #Innovation #medtech #medicaldevices https://lnkd.in/dc4crv9G

FDA greenlights Momentis’ robotic surgery device for hernia repair 

FDA greenlights Momentis’ robotic surgery device for hernia repair 

medicaldevice-network.com

Eyal Lifschitz

Co-Founder & General Managing Partner at Peregrine Ventures

2mo

That’s huge!! Amazing work!

Sandra Morgan

Board Director and Advisor, Healthcare, Medical Technology, and Pharmaceutical

2mo

Fantastic news! Congratulations, Peregrine Ventures, Momentis Surgical™, Eyal Lifschitz, and Dvir Cohen Thank you, Frederic H. Moll for your guidance and support. #roboticsurgery #herniarepair

Congrats! Really amazing journey 👏

See more comments

To view or add a comment, sign in

Explore topics